Genetically engineered cell line for detecting infectious herpes

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435 8, 435 691, 435 697, 435 698, 435 701, 4351723, 435207, 4352351, 4352402, 4353201, 536 221, 536 234, 536 2372, 536 241, C12Q 170, C12Q 166, C12P 2106, C12N 500

Patent

active

054181321

ABSTRACT:
A diagnostic assay for detecting the presence of an infectious herpes virus in a specimen and a genetically engineered cell line for use in such assay are disclosed. The cell line used in the assay expresses a reporter gene only if infectious herpes virus is present in the specimen. The assay involves inoculating a DNA-transfected cell line with a specimen suspected of containing a herpes virus, allowing a sufficient period of time for the herpes virus infectious cycle to proceed, and detecting and quantifying the number of herpes virus-infected cells to determine the number of infectious herpes virus virions in the specimen. The cell line is a DNA-transfected cell line susceptible to infection by a herpes virus which is stably transformed with a chimeric gene comprising a herpes virus inducible promoter and a gene coding for an enzyme, the expression of the enzyme being dependent upon and quantitatively proportional to the presence of herpes virus. A kit for such assay is also provided.

REFERENCES:
patent: 5070012 (1991-12-01), Nolan et al.
Herpes Simplex Virus Detection by Macroscopic Reading After Overnight Incubation and Immunoperoxidase Staining; Ziegler et al. J. Clin. Micro. 1985 26:2013-2017.
Establishment of PCR for the Early Diagnosis of Herpes Simplex Encephalitis; Puckhammer-Stockl et al. J. Med. Virol. 1990 32:77-82.
Activation of a .beta.-galactosidase Recombinant Provirus: Applicatio to Titration of Human Immunodeficiency Virus (HIV) and HIV-Infected Cells; D. Rocancourt et al. J. Virol. 1990 64:2660-2668.
Exploitation of a Rapid and Sensitive Assay to Analyze Transactivation of the Human Immunodeficiency Virus Type 1 HIV-1 Long Terminal Repeat; Roberts C. M. et al., Antiviral Chem Chemother 1 (2). 1990. 139-148.
Herpes Simplex Virus Type-1 Induced Ribonucleotide Reductase Activity is Dispensable for Virus Growth and DNA Synthesis: Isolation and Characterization of an ICP6 lacZ Insertion Mutant; Goldstein, David J. et al., J. Virol. 1988 62(1) 196-205.
Evaluation of Immunologic Tests for the Detection of Ocular Herpes Simplex Virus; Kowalski et al. Opthal. (1989) 96:1583-1586.
Infection of Cultured Central Nervous System Neurons with a Defective Herpes Simplex Virus 1 Vector Results in Stable Expression of Escherichia coli beta-galactosidase; Geller, A. I. et al., Proc. Natl Acad. Sci. U.S.A. (USA), 1990, 87/3 (1149-1153) (Abstract Only).
Mutational Analysis of the Sequence Encoding ICPO From Herpes Simplex Virus Type 1; Chen J. X. et al., Virology (United States) Jan. 1991, 180(1) p. 207-220 (Abstract only).
A System, Using Neural Cell Lines, to Characterize HSV-1 Vectors Containing Genes Which Affect Neuronal Physiology, or Neuronal Promoters; Geller, A. I., J. Neurosci. Methods (Netherlands), 1991, 36/1 (91-103) (Abstract only).
Transcriptionally Defective Retroviruses Containing lacZ for the in situ Detection of Endogenous Genes and Developmentally Regulated Chromatin; Kerr, W. G. et al., Cold Spring Harbor Symp. Quant. Biol., 54(2), 767-76, 1989 (Abstract only).
Detection and Serotyping of Herpes Simplex Virus in MRC-5 Cells by Use of Centrifugation and Monoclonal Antibodies 16 h Postinoculation; Gleaves et al. J. Clin. Micro. 1985 21;29-32.
Retrovirus Long Terminal Repeats Activate Expression of Coding Sequences for the Herpes Simplex Virus Thymidine Kinase EC-2.7.1.21 Gene; Joyner A. et al., Proc Natl Acad Sci U S A 79 (5). 1982. 1573-1577 (Abstract only).
Beta-galactosidase as a Marker in the Peripheral and Neural Tissues of the Herpes Simplex Virus-Infected Mouse; Ho D. Y. et al., Virology (USA), 1988, 167/1 (279-283) (Abstract only).
A Defective HSV-1 Vector Expresses Escherichia Coli Beta-galactosidase in Cultured Peripheral Neurons, Geller A. I. et al., Science (USA), 1988, 241/4873 (1667-1669) (Abstract only).
Inhibition by Interferon of Herpes Simplex Virus Type 1-Activated Transcription of tat-defective Provirus; Popik and Pitha, Proc. Natl Acad Sci USA, Nov. 1991, pp. 9573-9577.
Activation of human immunodeficiency by herpesvirus infection: Identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1; Mosca J. D. et al., Proc. Natl. Acad. Sci. USA, Nov. 1987, vol. 84, pp. 7408-7412.
Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus; Mosca J. D. et al., Nature, vol. 325, Jan. 1987, pp. 67-70.
Reliable Transient Promoter Assay Using Fluorescein-di-.beta.-D-galactopyranoside Substrate; Ikenaka, Kazuhiro et al., DNA and Cell Biology, vol. 9, No. 4, 1990, pp. 279-286.
An insertion vector for the analysis of gene expression during herpes simplex virus infection; Weir, Jerry P. et al., Gene 89 (1990) 271-274.
Towards a New Method of Detection of Human Retrovirus: Activation of HIV-1 LacZ Recombinant Provirus by the tat Gene Product; Bonnerot, Claire et al., C. R. Acad. Sci. Paris, t. 307, Serie III, pp. 311-316, 1988.
A Novel system for screening antiretroviral agents; Savatier, Nathalie et al., Journal of Virological Methods, 26 (1989) 229-236.
Quantitative Analysis of Gene Suppression in Integrated Retrovirus Vectors; Emerman, Michael et al., Molecular and Cellular Biology, Mar. 1986, pp. 792-800.
Separation and Characterization of Herpes Simplex Virus Type 1 Immediate-Early mRNA's; Watson, Roger J., Journal of Virology, Jul. 1979, pp. 42-52.
Detection of Replication-Competent and Pseudotyped Human Immunodeficiency Virus with a Sensitive Cell Line of the Basis of Activation of an Integrated .beta.-Galactosidase Gene; Kimpton, Jaculyn et al., Journal of Virology, Apr. 1992, pp. 2232-2239.
A Bi-Functional Reporter Plasmid for the Simultaneous Transient Expression Assay of Two Herpes Simplex Virus Promoters; Flsanagan W. Michael et al., Virus Genes, 1:1, 61-71, 1987.
Abstract of International Publication No. WO 9102797 titled Indicator Cells for Detection of Retro-Virus-Contg. Marker Gene Activated by Retro-Viral Infection; Nicolas J. F. et al. (Aug. 17, 1989).
Abstract of International Publication No. WO 8803167 titled Recombinant Retrovirus Lacking Sequences for Viral Proteins-Replaced by Gene for Marker Protein, Useful for Diagnosing Infection and Assessing Infective Capacity; Nicolas, J. F. et al. (Oct. 31, 1986).
Abstract of International Publication No. WO 8903878 titled Vectors Activatable by Retro-Viral Trans-Activator-for Prodn. of Indicator Cells for Retrovirus Detection, esp. in AIDs Diagnosis; Nicholas, J. F. et al. (May 5, 1989).
Abstract of European Publication No. EP-331356 titled Expression fo HIV Binding Proteins-Using Coding for CD-4 Receptor Protein and E Coli, Streptomyces and Yeast Hosts; Arthos, J. et al. (Sep. 6, 1989).
Abstract of European Publication No. EP-363127 titled Enhanced Expression in Transformed Eukaryotic Cells O Using poly-GT Element and Immediate-Early Gene prod. of Large DNA Virus, Berg, D. T. et al. (Apr. 11, 1990).
Abstract of French Publication No. FR2620030 titled Plasmid and Viral Vectors for Expression HIV-2 Viral Protein-Useful in Anti-AIDS Vaccines, and their Derived Proteins and Diagnostic Antibodies; Kieny, M. P. et al. (Mar. 10, 1989).
Abstract of European Patent No. EP 441582 titled Human Immunodeficiency Virus tat Gene and TAR Element in gene Expression in Yeast; Dykes, Colin William et al. (Aug. 14, 1991).
A .beta.-galactosidase Hybrid Protein Targeted to Nuclei as a Marker for Developmental Studies; Bonnerot, Claire et al., Chemical Abstracts, vol. 107, 1987 p. 158.
Chang et al "A Gene Delivery/Recall System . . . " Virology 185 439-440 1991.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Genetically engineered cell line for detecting infectious herpes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Genetically engineered cell line for detecting infectious herpes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetically engineered cell line for detecting infectious herpes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2139961

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.